Advertisement

Topics

Domain Therapeutics Company Profile

08:29 EST 19th December 2018 | BioPortfolio

Domain Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), one of the best classes of drug targets.

Domain Therapeutics is using its innovative and proprietary technology platform DTect-All™ to identify orthosteric and allosteric ligands of GPCRs, including the so called Silent Allosteric Modulators (SAMs) that represent a unique source of compounds that cannot be discovered by standard technologies. DTect-All™ is able to address difficult GPCRs such as orphan and peptidic GPCRs.

The company’s pipeline is composed of new chemical entities ranging from hits to optimized leads targeting hot GPCRs for leading indications such as Parkinson’s disease, schizophrenia, Alzheimer’s disease and diabetes.

Location

BIOPARC
Boulevard Sébastien Brant
ILLKIRCH-STRASBOURG
67400
FR

Contact

Phone: +33 3 90 40 61 50
Fax: +33 3 90 40 61 55
Email: contact@domaintherapeutics.com


News Articles [780 Associated News Articles listed on BioPortfolio]

Boehringer and Domain Therapeutics form CNS drug discovery alliance

Boehringer Ingelheim has signed a drug discovery collaboration and licensing agreement with Domain Therapeutics for the development of new drugs...Read More... The post Boehringer and Domain Therapeut...

Boehringer Ingelheim, Domain Launch CNS Drug Discovery Partnership

Boehringer Ingelheim will partner with Domain Therapeutics to discover new drugs designed to treat Central Nervous System (CNS) disorders by targeting G Protein-Coupled Receptors (GPCRs), Domain said ...

Boehringer enters CNS drug discovery deal with Domain

Boehringer Ingelheim and Domain Therapeutics agreed to work together to research and develop an undisclosed number of therape -More- 

Uniregistry Calls for Domain Name 'Bill of Rights' in the Wake of Call for Universal Web Contract

GRAND CAYMAN, Cayman Islands, Nov. 7, 2018 /PRNewswire/ -- Uniregistry, the world-renowned domain name registration company called today for the creation of a domain name Read more...

#news #biotech Boehringer inks pact with Domain for GPCR neurology drugs

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Boehringer inks pact with Domain for GPCR neurology drugs .French-Canadian bi...

The ZZ domain of p300 mediates specificity of the adjacent HAT domain for histone H3

The .ME Registry Celebrates 10 Years With the Launch of IDNs

COLUMBUS, Ohio, Nov. 6, 2018 /PRNewswire/ -- To celebrate the first decade of .ME domain name launch, the .ME Registry, operator of .ME domain name Read more...

Name Experts, LLC secures exclusive on Toner.com - a category defining global domain

BALTIMORE, Oct. 23, 2018 /PRNewswire/ -- Today, NameExperts.com announces the exclusive representation of the highly searched and sought after domain name, Toner.com. Toner dot com Read more...

PubMed Articles [1333 Associated PubMed Articles listed on BioPortfolio]

Protein engineering allows for mild affinity-based elution of therapeutic antibodies.

Presented here is an engineered protein domain, based on Protein A, that displays a calcium-dependent binding to antibodies. This protein, Z, is shown to efficiently function as an affinity ligand for...

Investigation of the interaction of allergens of Glycine max with IgE-antibody for designing of peptidomimetics based anti-allergen.

Allergen induced IgE dependent type I hypersensitivity is the main cause of the allergy, which would be a burden on medical setup in coming years. Allergens of Glycine max have been isolated, and thei...

Autophagic Regulation of p62 is Critical for Cancer Therapy.

Sequestosome1 (p62/SQSTM 1) is a multidomain protein that interacts with the autophagy machinery as a key adaptor of target cargo. It interacts with phagophores through the LC3-interacting (LIR) domai...

Open Set Domain Adaptation for Image and Action Recognition.

Since annotating and curating large datasets is very expensive, there is a need to transfer the knowledge from existing annotated datasets to unlabelled data. Data that is relevant for a specific appl...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Clinical Trials [394 Associated Clinical Trials listed on BioPortfolio]

Ocular Imaging With Spectral Domain Optical Coherence Tomography

The purpose of this study is to analyze macular retinal thickness and macular volume using the spectral domain - optical coherence tomography (SD-OCT) in normal eyes and in eyes with vario...

Pilot Study To Evaluate Optical Frequency Domain Imaging For Diagnosis Of Central Airway Disease

To evaluate the potential of a new imaging device, termed Optical Frequency Domain Imaging (OFDI), in the early diagnosing of pulmonary malignancies in the central airways.

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Protocol of Multi-domain Attention Training

This study sought to investigate the changes in attention in older adults with mild cognitive impairment after Multi-domain Attention Training .

Companies [1481 Associated Companies listed on BioPortfolio]

Domain Therapeutics

Domain Therapeutics is a biopharmaceutical company located in Strasbourg, France, dedicated to the discovery and early development of small molecules targeting G-coupled Protein Receptors (GPCRs), o...

Epik.com

Epik.com was founded in 2009 with a simple goal - to help domain investors evolve from a singular dependence on domain parking to a more diversified array of value creation strategies that unlock the ...

NameMedia, Inc

Whether you are looking for the perfect domain name for a new web site or simply trying to increase traffic to your existing web site, you will find it at BuyDomains. With our exclusive selection of o...

NameMedia, Inc.BuyDomains Division

Whether you are looking for the perfect domain name for a new web site or simply trying to increase traffic to your existing web site, you will find it at BuyDomains. With our exclusive selection of o...

Domain

Domain devotes considerable attention and resources to the earliest stage companies that we incorporate ourselves and initially support within our offices. In these instances, Domain forms a company ...

More Information about "Domain Therapeutics" on BioPortfolio

We have published hundreds of Domain Therapeutics news stories on BioPortfolio along with dozens of Domain Therapeutics Clinical Trials and PubMed Articles about Domain Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Domain Therapeutics Companies in our database. You can also find out about relevant Domain Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record